This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Benzinga·5d ago
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Baird analyst Quinn Fredrickson downgraded Teradyne Inc(NASDAQ:TER) from Outperform to Neutral and maintained the price target of $420. Teradyne closed at $383.15 on Thursday. See how other analysts view this stock.
HSBC analyst Jonathan Brandt downgraded Ternium SA(NYSE:TX) from Buy to Hold and raised the price target from $53 to $55. Ternium shares closed at $54.21 on Thursday. See how other analysts view this stock.
Canaccord Genuity analyst Richard Close downgraded Health Catalyst Inc (NASDAQ:HCAT) from Buy to Hold and cut the price target from $3 to $1.8. Health Catalyst closed at $1.63 on Thursday. See how other analysts view this stock.
JP Morgan analyst Samik Chatterjee downgraded DoubleVerify Holdings Inc (NYSE:DV) from Overweight to Neutral and announced a $13.6 price target. DoubleVerify shares closed at $13.31 on Thursday. See how other analysts view this stock.
JP Morgan analyst Tomohiko Sano downgraded Limbach Holdings, Inc. (NASDAQ:LMB) from Neutral to Underweight and cut the price target from $60 to $50. Limbach closed at $42.75 on Thursday. See how other analysts view this stock.
Considering buying TER stock? Here’s what analysts think:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.